EYE ON DIAGNOSTICS: Detecting AMI with cardiac biomarkers
Raymonde Ann Brown APRN-BC, CNE, PhD

October 2009 
Volume 39  Number 10
Pages 63 - 63
  PDF Version Available!


WHEN A PATIENT has chest discomfort suggestive of myocardial ischemia or anginal equivalent symptoms, such as dyspnea, the 12-lead ECG and serum cardiac biomarkers are used, in conjunction with patient history, to help identify or rule out acute coronary syndromes (ACS). ACS is a spectrum of clinical syndromes that include unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment-elevation myocardial infarction (STEMI). 1 In this article, I'll explain the critical role of serum cardiac biomarkers in identifying acute myocardial infarction (AMI).

Multiple biomarkers

In AMI, damaged myocytes release enzymes and proteins normally ...

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

Featured Jobs

Benefits of Membership

FREE E-Newsletters
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues

Join our CESaver program to earn up to 100 contact hours for only $34.95
Register Now

Lippincott's NursingCenter.com
Explore a world of online resources

Become a Member